Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
358366,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,61.04,04/06/2015,GNRL,319267911
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,28.06,03/25/2014,GNRL,148409070
358366,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,20.00,05/08/2015,GNRL,318836938
358366,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.49,01/28/2014,GNRL,187747324
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.44,04/25/2014,GNRL,150097416
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,19.37,03/11/2015,GNRL,339771048
358366,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.36,10/30/2013,GNRL,13986225
358366,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,19.11,06/28/2014,GNRL,199573736
358366,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,17.74,02/28/2014,GNRL,163261218
358366,GNRL,"AbbVie, Inc.",IL,100000000204,16.39,10/06/2013,GNRL,104616048
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.39,07/17/2014,GNRL,150199552
358366,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.24,12/12/2013,GNRL,32388128
358366,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,16.09,09/20/2013,GNRL,100815836
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.05,03/19/2014,GNRL,148250337
358366,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,15.72,11/16/2015,GNRL,275555676
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.44,06/19/2014,GNRL,149095314
358366,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,15.29,10/24/2013,GNRL,101236970
358366,GNRL,"HOLOGIC INC",MA,100000010400,15.29,08/30/2013,GNRL,223004536
358366,GNRL,"Eisai Inc.",NJ,100000000136,15.28,06/25/2014,GNRL,184678154
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.25,05/02/2014,GNRL,148550704
358366,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,15.19,05/02/2014,GNRL,199573732
358366,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.64,04/24/2014,GNRL,194472055
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.54,09/18/2014,GNRL,149302000
358366,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.44,07/15/2014,GNRL,196805352
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.44,01/09/2015,GNRL,339465902
358366,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.21,01/30/2014,GNRL,160810000
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.07,12/04/2015,GNRL,339440674
358366,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.98,09/11/2015,GNRL,290346616
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.77,09/26/2014,GNRL,149738354
358366,GNRL,"Eisai Inc.",NJ,100000000136,13.77,07/23/2014,GNRL,184678158
358366,GNRL,"Abbott Laboratories",IL,100000010680,13.76,08/01/2013,GNRL,102313930
358366,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,13.67,11/19/2013,GNRL,14045903
358366,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.57,04/02/2014,GNRL,196804084
358366,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,13.52,05/23/2014,GNRL,163224052
358366,GNRL,"Pfizer Inc.",NY,100000000286,13.45,04/15/2014,GNRL,205531168
358366,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.41,07/22/2014,GNRL,196807900
358366,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,13.33,06/06/2014,GNRL,199573728
358366,GNRL,"Impax Laboratories, Inc.",CA,100000010694,13.29,09/25/2013,GNRL,31719122
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.29,03/10/2014,GNRL,150923288
358366,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,13.24,09/17/2013,GNRL,14045904
358366,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.17,01/09/2014,GNRL,216117438
358366,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.16,08/02/2013,GNRL,31900353
358366,GNRL,"Pfizer Inc.",NY,100000000286,13.15,07/31/2014,GNRL,206151296
358366,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,12.98,09/03/2014,GNRL,188050348
358366,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,12.83,07/30/2014,GNRL,187992734
358366,GNRL,"Amgen Inc.",CA,100000000203,12.81,01/09/2014,GNRL,138224706
358366,GNRL,"Amgen Inc.",CA,100000000203,12.72,08/21/2015,GNRL,297707050
358366,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.62,03/05/2014,GNRL,196803286
358366,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,12.62,04/27/2014,GNRL,199573726
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.62,01/21/2015,GNRL,256315588
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.44,08/30/2013,GNRL,12122393
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.28,09/09/2015,GNRL,255924476
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.19,09/08/2015,GNRL,339331734
358366,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.12,10/16/2013,GNRL,101653564
358366,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,12.12,07/01/2014,GNRL,217664248
358366,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.12,05/30/2014,GNRL,194471994
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.04,10/20/2015,GNRL,339315910
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.04,10/20/2015,GNRL,339315914
358366,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.99,04/23/2015,GNRL,337106004
358366,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.91,11/14/2013,GNRL,32388127
358366,GNRL,"Pfizer Inc.",NY,100000000286,11.80,06/13/2014,GNRL,207032862
358366,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.75,11/07/2013,GNRL,100859682
358366,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.72,08/26/2014,GNRL,194471978
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,11.64,05/15/2015,GNRL,339267136
358366,GNRL,"Astellas Pharma US Inc",IL,100000000137,11.57,05/15/2014,GNRL,168894344
358366,GNRL,"Grifols USA, LLC",CA,100000005420,11.57,12/16/2014,GNRL,220249986
358366,GNRL,"Pfizer Inc.",NY,100000000286,11.54,04/17/2015,GNRL,323134190
358366,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.48,06/10/2014,GNRL,187918832
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.28,08/20/2013,GNRL,12158705
358366,GNRL,"Amgen Inc.",CA,100000000203,11.23,10/22/2013,GNRL,8976348
358366,GNRL,"Eisai Inc.",NJ,100000000136,11.10,08/23/2014,GNRL,184678162
358366,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,11.03,01/14/2014,GNRL,147057269
358366,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.96,09/24/2013,GNRL,32388126
358366,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.91,08/14/2014,GNRL,156607762
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.89,12/15/2015,GNRL,256198648
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.87,03/25/2014,GNRL,148481352
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.82,06/24/2015,GNRL,339200966
358366,GNRL,"Pfizer Inc.",NY,100000000286,10.80,07/18/2014,GNRL,207001387
358366,GNRL,"HOLOGIC INC",MA,100000010400,10.80,07/02/2014,GNRL,181520130
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.74,09/16/2014,GNRL,148424624
358366,GNRL,"Pfizer Inc.",NY,100000000286,10.71,10/02/2013,GNRL,205872014
358366,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.66,04/30/2014,GNRL,194471988
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.64,04/10/2015,GNRL,339188922
358366,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.62,11/06/2013,GNRL,6644369
358366,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.44,09/09/2014,GNRL,156607760
358366,GNRL,"Pfizer Inc.",NY,100000000286,10.38,04/11/2014,GNRL,207236338
358366,GNRL,"Astellas Pharma US Inc",IL,100000000137,10.37,04/22/2014,GNRL,168872296
358366,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.36,01/28/2015,GNRL,318836910
358366,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.35,04/12/2014,GNRL,199573722
358366,GNRL,"Pfizer Inc.",NY,100000000286,10.34,11/25/2013,GNRL,205087750
358366,GNRL,"Pfizer Inc.",NY,100000000286,10.34,01/22/2014,GNRL,205933560
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.15,04/02/2015,GNRL,339148036
358366,GNRL,"Astellas Pharma US Inc",IL,100000000137,10.10,08/22/2013,GNRL,101679368
358366,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.08,08/07/2014,GNRL,194472046
358366,GNRL,"Pfizer Inc.",NY,100000000286,9.88,09/12/2014,GNRL,206257284
358366,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.68,08/08/2014,GNRL,156607756
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,9.53,12/02/2015,GNRL,339129080
358366,GNRL,"Pfizer Inc.",NY,100000000286,9.26,02/11/2014,GNRL,206679280
358366,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.16,01/23/2014,GNRL,156607748
358366,GNRL,"Pfizer Inc.",NY,100000000286,9.10,05/20/2014,GNRL,206599152
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,8.87,07/23/2015,GNRL,339102434
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,8.68,10/15/2015,GNRL,339096150
358366,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.53,02/14/2014,GNRL,194472030
358366,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.47,01/16/2014,GNRL,156607746
358366,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.22,01/08/2014,GNRL,194472024
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,7.82,12/30/2015,GNRL,339072214
358366,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.69,04/18/2014,GNRL,194472039
358366,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.61,09/11/2014,GNRL,194472006
358366,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.89,03/06/2014,GNRL,156607754
358366,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,5.84,01/07/2015,GNRL,336829762
358366,GNRL,"Pfizer Inc.",NY,100000000286,5.57,05/16/2014,GNRL,206503556
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.45,01/28/2015,GNRL,338987606
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.66,08/26/2015,GNRL,338925858
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.64,02/23/2015,GNRL,338924702
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.57,10/29/2015,GNRL,338920908
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.40,11/16/2015,GNRL,338909084
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.30,10/12/2015,GNRL,338901972
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.25,10/20/2015,GNRL,338900792
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.15,10/29/2015,GNRL,338898636
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.04,09/22/2015,GNRL,338896492
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.71,07/23/2015,GNRL,338887710
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.50,09/22/2015,GNRL,338883038
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.47,12/30/2015,GNRL,338882412
358366,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1.38,09/26/2014,GNRL,148512148
358366,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1.11,08/07/2014,GNRL,194472000
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.76,09/08/2015,GNRL,338868482
358366,GNRL,"Pfizer Inc.",NY,100000000286,0.68,07/18/2014,GNRL,206397698
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.58,12/02/2015,GNRL,338864212
358366,GNRL,"Pfizer Inc.",NY,100000000286,0.54,04/10/2014,GNRL,207296792
358366,GNRL,"Pfizer Inc.",NY,100000000286,0.51,05/16/2014,GNRL,206467078
358366,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.50,01/23/2014,GNRL,156607750
358366,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.50,06/24/2015,GNRL,338861828
358366,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.44,03/06/2014,GNRL,156607752
358366,GNRL,"Pfizer Inc.",NY,100000000286,0.24,07/31/2014,GNRL,206063038
358366,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.22,08/08/2014,GNRL,156607758
